Skip to main content
$1.57 -$0.10 (-6.0%)

04:00 PM EDT on 07/23/21

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $1.57 Mkt Cap $71.3M
Open $1.65 P/E Ratio 0.00
Prev. Close $1.57 Div. (Yield) $0.00 (0.0%)
Daily Range $1.56 - $1.67 Volume 19,740
52-Wk Range $1.46 - $7.02 Avg. Daily Vol. 2,326,932

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

147 Outperform
72 Underperform
 

All-Star Players

12 Outperform
21 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (64.45)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: -51.01

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -213.54

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (64.45) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +291.44

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +735.37

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.06 2/10/2009 Underperform 3W $2.66 -40.98% +419.11% +460.09 0 Comment
anticitradeshort 29.01 4/20/2009 Underperform NS $2.27 -30.84% +419.83% +450.67 0 Comment
Spelunkin 24.77 11/3/2009 Underperform 5Y $10.39 -84.89% +324.21% +409.10 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -84.14% +322.63% +406.77 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -84.14% +322.63% +406.77 0 Comment
MSFOBV1YH 86.48 11/4/2009 Underperform 5Y $10.93 -85.64% +317.10% +402.73 0 Comment
ModernDayWarrior 23.99 10/29/2009 Underperform 5Y $9.58 -83.61% +318.37% +401.98 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -86.80% +314.15% +400.95 0 Comment
mathieugp 25.60 9/28/2009 Underperform 3M $7.87 -80.05% +319.72% +399.77 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -86.92% +307.67% +394.59 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.